Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06415396
Status:
COMPLETED
Last Update Posted:
2024-05-16
First Post:
2024-05-10
Brief Title:
Effects of Extracorporeal Shock Wave Therapy ESWT and Low Intensity Laser Therapy LLLT Added to Complete Decongestive Therapy CDT on Extremity Volume Pain Intensity Functional Status and Quality of Life in Patients With Postmastectomy Stage 2 Lymphedema
Sponsor:
Ankara City Hospital Bilkent
Organization:
Ankara City Hospital Bilkent
Study Overview
Official Title:
Effects of Extracorporeal Shock Wave Therapy ESWT and Low Intensity Laser Therapy LLLT Added to Complete Decongestive Therapy CDT on Extremity Volume Pain Intensity Functional Status and Quality of Life in Patients With Postmastectomy Stage 2 Lymphedema
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aimed to comparatively investigate the effects of ESWT and LLLT added to conventional CDT which is the standard treatment for breast cancer-related lymphedema on patients limb volume pain intensity functional status and quality of life
Detailed Description:
after being informed study and potential risks all patient giving written informed consent will undergo screening period determine eligibility for study entry The patients who meet the eligibility recruitments will get treatment into three groups in conventional complet decongestive therapy CDT program electrocorporeal shock wave therapy ESWT combined with CDT program and low level laser therapy LLLT combined with CDT program
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None